Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/89BIO-INC-74010954/attualita/89bio-Inc-raggiunge-un-allineamento-con-la-FDA-e-l-EMA-sul-programma-di-Fase-3-per-pegozafermin-ne-45501340/?utm_source=whatsapp&utm_medium=social&utm_campaign=share